These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13774234)

  • 1. Color stability of tablet formulations. IV. Protective influence of various colored glasses on the fading of tablets.
    SWARTZ CJ; LACHMAN L; URBANYI T; COOPER J
    J Pharm Sci; 1961 Feb; 50():145-8. PubMed ID: 13774234
    [No Abstract]   [Full Text] [Related]  

  • 2. Color stability of tablet formulations. II. Influence of light intensity on the fading of several water-soluble dyes.
    LACHMAN L; SWARTZ CJ; URBANYI T; COOPER J
    J Am Pharm Assoc Am Pharm Assoc; 1960 Mar; 49():165-9. PubMed ID: 13853521
    [No Abstract]   [Full Text] [Related]  

  • 3. Color stability of tablet formulations. V. Effect of ultraviolet absorbers on the photostability of colored tablets.
    LACHMAN L; URBANYI T; WEINSTEIN S; COOPER J; SWARTZ CJ
    J Pharm Sci; 1962 Apr; 51():321-6. PubMed ID: 14461375
    [No Abstract]   [Full Text] [Related]  

  • 4. Color stability of tablet formulations. I. Measurement of changes in individual tablet reflectance.
    URBANYI T; SWARTZ CJ; LACHMAN L
    J Am Pharm Assoc Am Pharm Assoc; 1960 Mar; 49():163-4. PubMed ID: 13855182
    [No Abstract]   [Full Text] [Related]  

  • 5. Color stability of tablet formulations. VI. Preliminary study of temperature dependency of colorant loss in tablets at various pH levels.
    SWARTZ CJ; LACHMAN L; URBANYI T; WEINSTEIN S; COOPER J
    J Pharm Sci; 1962 Apr; 51():326-9. PubMed ID: 13918804
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of sunscreening agents on color stability of tablets coated with certified dyes III: FD&C Yellow No. 6.
    Hajratwala BR; Hennig AJ
    J Pharm Sci; 1977 Jan; 66(1):107-9. PubMed ID: 833722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic error associated with apparatus 2 of the USP dissolution test V: Interaction of two tableted prednisone formulations with glass and plastic vessels.
    Cox DC; Furman WB
    J Pharm Sci; 1984 Aug; 73(8):1125-7. PubMed ID: 6491917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid determination of color stability of tablet formulations.
    Turi P; Brusco D; Maulding HV; Tausendfreund RA; Michaelis AF
    J Pharm Sci; 1972 Nov; 61(11):1811-4. PubMed ID: 4652657
    [No Abstract]   [Full Text] [Related]  

  • 9. STABILITY OF CERTIFIED DYES IN TABLETS. II. FADING OF FD&C RED NO. 3 AND FD&C RED NO. 3 ALUMINUM LAKE IN THREE TABLET FORMULAS.
    GOODHART FW; EVERHARD ME; DICKCIUS DA
    J Pharm Sci; 1964 Mar; 53():338-40. PubMed ID: 14185029
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing impact of manufacturing and package configurations to photosensitive compounds.
    Carvalho TC; Escotet ML; Lin J; Sprockel OL
    Drug Dev Ind Pharm; 2016; 42(6):936-44. PubMed ID: 26460067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoinduced color changes in two different qualities of riboflavin in the solid state and in various tablet formulations photoreactivity of biologically active compounds. XX.
    Sue-Chu M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jul; 64(7):428-35. PubMed ID: 19694178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color stability of tablet formulations. III. Comparative light fastness of several water-soluble dyes and their corresponding lakes.
    LACHMAN L; WEINSTEIN S; SWARTZ CJ; URBANYI T; COOPER J
    J Pharm Sci; 1961 Feb; 50():141-4. PubMed ID: 13758062
    [No Abstract]   [Full Text] [Related]  

  • 14. Preformulation studies in a drug development program for tablet formulations.
    Graffner C; Johansson ME; Nicklasson M; Nyqvist H
    J Pharm Sci; 1985 Jan; 74(1):16-20. PubMed ID: 3981410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the physical properties of tablets and tablet excipients. V. Film coating for protection of a light-sensitive tablet-formulation.
    Nyqvist H; Nicklasson M; Lundgren P
    Acta Pharm Suec; 1982; 19(3):223-8. PubMed ID: 7113729
    [No Abstract]   [Full Text] [Related]  

  • 16. Photoreactivity of biologically active compounds. XVIII. Photostability of ofloxacin in the solid state and in a tablet formulation.
    Tønnesen HH; Brunsvik A; Løseth K; Bergh K; Gederaas OA
    Pharmazie; 2007 Feb; 62(2):105-11. PubMed ID: 17341028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated hot-melt extrusion - injection molding continuous tablet manufacturing platform: Effects of critical process parameters and formulation attributes on product robustness and dimensional stability.
    Desai PM; Hogan RC; Brancazio D; Puri V; Jensen KD; Chun JH; Myerson AS; Trout BL
    Int J Pharm; 2017 Oct; 531(1):332-342. PubMed ID: 28844899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nondestructive and on-line monitoring of tablets using light-induced fluorescence technology.
    Lai CK; Zahari A; Miller B; Katstra WE; Cima MJ; Cooney CL
    AAPS PharmSciTech; 2004 Jan; 5(1):E3. PubMed ID: 15198524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ.
    Doreth M; Hussein MA; Priemel PA; Grohganz H; Holm R; Lopez de Diego H; Rades T; Löbmann K
    Int J Pharm; 2017 Mar; 519(1-2):343-351. PubMed ID: 28115260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.